CoMind raises $102.5 million for a non-invasive bedside brain monitor
The London start-up uses laser light through a forehead sensor to track brain blood flow and other measures in intensive care and surgery.
London-based CoMind has raised funding that brings its total to $102.5 million, including a $60 million round led by Plural. The company is developing CoMind One, an adhesive forehead sensor that uses infrared laser light, similar in principle to lidar, to measure brain blood flow and other physiology continuously at the bedside. Today these measures often require drilling into the skull.
CoMind plans to use the money for regulatory work, clinical trials and manufacturing, and has said it hopes to start selling in 2027. Uses include intensive care, cardiac surgery and traumatic brain injury.
Learn more: fNIRS and optical imaging · Invasive vs. non-invasive